One of the hallmarks of our IBC signature was the presence of numerous NF-κB target genes, suggesting NF-κB hyperactivation in IBC (Van Laere et al, 2005, 2006b). The gene discussed is NFKB1; the disease is inflammatory breast carcinoma.